Abstract
TWO major unanswered questions concerning the specificity of antibodies are: how do structurally different antigens bind with high affinity to the same antibody, and what are the limits of the antibody combining site complementarity and flexibility that contribute to such crossreactivity? We report here a comparative analysis of the X-ray structures of five conformationally different steroids in complex with the Fab′ fragment of an anti-progesterone antibody DB3 at 2.7 Å. This antibody is unable to complement completely the shape of the hydrophobic antigen so that crossreactivity occurs with other ligands without major structural rearrangements of the binding site. Antigen specificity can be explained through conserved interactions of DB3 with the steroid D-ring, whereas some of the crossreactivity is realized through different binding orientations of the steroid skeleton that place the A-ring into alternative pockets on the antibody surface. The restricted gene usage of the VGAM3.8 family in the generation of anti-progesterone monoclonal antibodies1,2 may be explained by the specific interaction of VH hallmark residues with the steroid D-ring. This first detailed structure of steroid interactions with a protein could be applied to the understanding of general mechanisms of steroid recognition as well as in the design of specific binding sites for small hydrophobic ligands.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Deverson, E., Berek, C., Taussig, M. J. & Feinstein, A. Eur. J. Immun. 17, 9–13 (1987).
Sims, M. J., Krawinkel, U. & Taussig, M. J. J. Immun. 149, 1642–1648 (1992).
Wright, L. J. et al. Nature 295, 415–417 (1982).
Ellis, S. T. et al. J. Endocrin. 118, 69–80 (1988).
Stura, E. A. et al. Immunology 62, 511–521 (1987).
Landsteiner, K. The Specificity of Serological Reactions (Dover, New York, 1962).
van Regenmortel, M. H. V. Immun. Today 10, 266–272 (1989).
Arevalo, J. H., Stura, E. A., Taussig, M. J. & Wilson, I. A. J. molec. Biol. 231, 103–118 (1993).
Duax, W. L. & Norton, D. A. Atlas of Steroid Structures Vol. 1 (Plenum, New York, 1975).
Griffin, J. F., Duax, W. L. & Weeks, C. M. Atlas of Steroid Structures Vol. 2 (Plenum, New York, 1984).
Burley, S. K. & Petsko, G. A. Science 229, 23–28 (1983).
Wilson, I. A. & Stanfield, R. L. Curr. Opin. struct. Biol. 3, 113–118 (1993).
Stanfield, R. L., Takimoto-Kamimura, M., Rini, J. M., Profy, A. T. & Wilson I. A. Structure (in the press).
Rini, J. M., Schulze-Gahmen, U. & Wilson, I. A. Science 255, 959–965 (1992).
Lee, B. & Richards, F. M. J. molec. Biol. 55, 376–400 (1971).
Bohacek, R. S. & McMartin, C. J. med. Chem. 35, 1671–1684 (1992).
Mudgett-Hunter, M., Anderson, W., Haber, E. & Margolies, M. N. Molec. Immun. 22, 477–488 (1985).
Taussig, M. J. et al. Immunology 72, 471–480 (1991).
Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S. & Foeller, C. Sequences of Proteins of Immunological Interest 5th edn (National Institutes of Health, Bethesda, 1991).
Berek, C. & Milstein, C. Immunol. Rev. 96, 23–41 (1987).
Alzari, P. M. et al. EMBO J. 9, 3807–3814 (1990).
Parhami-Seren, B., Kussie, P. H., Strong, R. K. & Margolies, M. N. J. Immun. 150, 1829–1837 (1993).
Lascombe, M-B., Alzari, P. M., Poljak, R. J. & Nisonoff, A. Proc. natn. Acad. Sci. U.S.A. 89, 9429–9433 (1992).
Evans, R. M. Science 240, 889–895 (1988).
Baulieu, E-E. Science 245, 1351–1357 (1989).
Strickler, R. C., Covey, D. F. & Tobias, B. Biochemistry 19, 4950–4954 (1980).
Luu-The, V. et al. Biochemistry 36, 8861–8865 (1991).
Brunger, A. T. X-PLOR version 2.1 (Yale University, 1990).
Jones, A. T. J. appl. Crystallogr. 11, 268–272 (1978).
Kabat, E. A. & Wu, T. T. J. Immun. 147, 1709–1719 (1991).
Ferrin, T. E., Huang, C. C., Jarvis, L. E. & Langridge, R. J. molec. Graphics 6, 13–27 (1988).
Connolly, M. L. Science 221, 709–713 (1983).
Gelin, B. R. & Karplus, M. Biochemistry 18, 1256–1268 (1979).
Upson, C. et al. IEEE comput. Graph. Applic. 9, 30–42 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arevalo, J., Taussig, M. & Wilson, I. Molecular basis of crossreactivity and the limits of antibody–antigen complementarity. Nature 365, 859–863 (1993). https://doi.org/10.1038/365859a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/365859a0
This article is cited by
-
Protein promiscuity and its implications for biotechnology
Nature Biotechnology (2009)
-
Targeting Pemphigus Autoantibodies through their Heavy-Chain Variable Region Genes
Journal of Investigative Dermatology (2007)
-
Comparison of antibody and albumin catalyzed hydrolysis of steroidalp-nitrophenylcarbonates
Applied Biochemistry and Biotechnology (1998)
-
Comparative docking studies on ligand binding to the multispecific antibodies IgE-La2 and IgE-Lb4
Journal of Computer-Aided Molecular Design (1996)
-
Monoclonal antibody affinities of structurally related modified nucleosides
Molecular and chemical neuropathology (1996)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.